基本信息 产品详情 公司简介 推荐产品
网站主页 化工产品目录 生物化工 抗体 ANTI-TP53INP1 POLYCLONAL ANTIBODY Anti-TP53INP1 Polyclonal Antibody
  • Anti-TP53INP1 Polyclonal Antibody

Anti-TP53INP1 Polyclonal Antibody

Anti-TP53INP1 Polyclonal Antibody
1600.00 100ul 起订
960.00 50ul 起订
北京 更新日期:2024-10-16

北京索莱宝科技有限公司

VIP9年
联系人:索莱宝
电话:010-50973130拨打
手机:4009686088 拨打
邮箱:3193328036@qq.com

产品详情:

中文名称:
Anti-TP53INP1 Polyclonal Antibody
英文名称:
Anti-TP53INP1 Polyclonal Antibody
Gene ID:
94241
Public Immunogen Range:
A synthetic peptide of human TP53INP1
Subcellular Locations:
Cytoplasm
Swiss Prot:
Q96A56
保存:
Store at -20°C. Avoid freeze / thaw cycles.
别名:
SIP;Teap;p53DINP1;TP53DINP1;TP53INP1A;TP53INP1B
产品编号:
K007786P
储存液:
Buffer: PBS with 0.03% Proclin300, 50% glycerol, pH7.3.
纯化方法:
Affinity purification
蛋白分子量:
27kDa
交叉反应:
Human Rat
克隆类型:
Polyclonal Antibody
免疫原:
A synthetic peptide of human TP53INP1
宿主:
Rabbit
稀释比例:
WB 1:200-1000. IHC 1:50-200.
性状:
液体
亚型:
IgG
应用:
WB IHC
英文名称:
Anti-TP53INP1 Polyclonal Antibody

背景资料

TP53INP1 (tumor protein p53-inducible nuclear protein 1), also known as p53DINP1, SIP or Teap, is a 240 amino acid protein that localizes to nuclear bodies and exists as two alternatively spliced isoforms, designated p53DINP1a and p53DINP1b. Expressed ubiquitously with higher expression in testis, pancreas and spleen tissue, TP53INP1 functions in response to double-stranded DNA breaks and regulates p53-mediated apoptosis, specifically by phosphorylating human p53 at Ser 46, an event that leads to cell death. Additionally, TP53INP1 is thought to interact with p73 and may be involved in the regulation of p73-controlled cell cycle progression. TP53INP1 expression is downregulated in pancreatic ductal adenocarcinomas, suggesting that, via its ability to induce cell death, TP53INP1 plays a role in tumor suppression.
Anti-TP53INP1 Polyclonal Antibody;抗体

公司简介

北京索莱宝科技有限公司是一家集研发、生产、销售、服务于一体的高科技生物企业。技术推广;技术转让;技术咨询;技术服务;生物试剂技术开发;销售生物试剂盒、实验室专用化学试剂、实验室专用设备、办公用品、化工产品(不含危险化学品)、计算机软件及辅助设备;货物进出口、技术进出口、代理进出口;委托加工生产生物制品、生化制品、化工产品(不含危险化学品);生产生物试剂盒;批发第一类医疗器械、第二类医疗器械;批发第三类医疗器械。

成立日期 (21年)
注册资本 1000万元
员工人数 50-100人
年营业额 ¥ 500万-1000万
经营模式 贸易,工厂,试剂
主营行业 分析化学,生物化工,化学试剂,医药原料,仪器耗材

Anti-TP53INP1 Polyclonal Antibody相关厂家报价

内容声明
拨打电话 立即询价